Psilocybin for Depression

Recent studies indicate that a 25 to 30 milligram dose of psilocybin, administered in one or two sessions, offers significant relief for those suffering from major depressive disorder. With 60% to 75% of participants reporting positive experiences and minimal adverse effects, the research highlights the potential of psilocybin as a viable treatment option. Various trials have compared its effectiveness against traditional antidepressants and therapy methods, emphasizing the need for further exploration in diverse demographic groups.